CYP19A1: rs10046 | |||||
---|---|---|---|---|---|
Endpoint | Cohort | T/T vs T/C, C/C patients (events) | Univariate model OR (95 % CI)a | Univariate model Interaction P valueb | Multivariable model OR (95 % CI)c |
Hot flashes/sweating | All patients | 446 (172) vs 1519 (676) | 0.78 (0.63, 0.97) | 0.03 | 0.83 (0.66, 1.03) |
Exemestane + OFS | 227 (77) vs 759 (334) | 0.65 (0.48, 0.89) | 0.67 (0.49, 0.93) | ||
Tamoxifen + OFS | 219 (95) vs 760 (342) | 0.94 (0.69, 1.27) | 1.04 (0.75, 1.43) | ||
Musculoskeletal events | All patients | 446 (110) vs 1520 (406) | 0.90 (0.70, 1.15) | 0.39 | 0.85 (0.66, 1.1) |
Exemestane + OFS | 227 (75) vs 759 (256) | 0.97 (0.71, 1.33) | 0.96 (0.69, 1.32) | ||
Tamoxifen + OFS | 219 (35) vs 761 (150) | 0.77 (0.52, 1.16) | 0.77 (0.51, 1.17) |